🇺🇸 FDA
Patent

US 9663521

Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis

granted A61KA61K31/519A61K31/695

Quick answer

US patent 9663521 (Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/519, A61K31/695, A61K45/06, A61P